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Abstract
Background: New approaches are being sought to safely reduce community antibiotic prescribing. A recent study
demonstrated that CRP testing resulted in decreased antibiotic prescribing for lower respiratory tract infection in
primary care. There is little other published primary care data available evaluating CRP in the treatment of lower
respiratory tract infections in routine clinical practice. This pilot study aims to describe the performance of near-
patient CRP testing, in a mixed payments health system. Specific areas to be reviewed included the integrity of the
study protocol, testing of data collection forma and acceptability of the intervention.
Patients: Patients over the age of 18 years, with acute cough and/or sore throat with a duration of one month or
less, in routine clinical practice.
Method: Design: A pilot with a cross-sectional design. The first 60 recruited patients were treated with routine
clinical management, and GP’s had no access to a CRP test. For the subsequent 60 patients, access to CRP testing
was available.
Participants: 3 GP’s in one Irish primary care practice recruited 120 patients, fulfilling the above criteria over five
months, from January 1 to May 31, 2010.
Main outcome measures: The primary outcome was antibiotic prescription at the index consultation. Secondary
outcomes were the numbers of delayed prescriptions issued, patient satisfaction immediately after consultation
and re-consultations and antibiotic prescriptions during 28 days follow-up.
Results: The protocol and data collection forms worked well and the intervention of CRP testing appeared
acceptable. Thirty-five (58%) patients in the no-test group received antibiotic prescriptions compared to 27 (45%) in
the test group. Both groups demonstrated similarly high level of patient satisfaction (85%). Fourteen (23%) patients
in the CRP test group re-attended within 28 days compared to 9 (15%) in the no-CRP test group.
Conclusion: This pilot study confirms the potential feasibility of a full trial in Irish general practice. Further
consideration of possible increased re-attendance rates in a mixed payments health system is appropriate. We
intend to pursue a larger trial in a newly established regional primary care research network.
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Acute respiratory tract infections are extremely common
in general practice and are the commonest reason for
general practitioner consultation [1]. Most of these
infections are self-limiting with limited if any benefit
from antibiotic use [2]. Excessive antibiotic use has sig-
nificant implications including cost, medicalisation of
self-limiting illness, increased potential for adverse
effects and development of resistance [2]. New
approaches to reduce antibiotic prescribing include
patient and doctor education, utilizing delayed antibiotic
prescribing and near-patient/point of care CRP testing
[3].
CRP testing is emerging as an important aspect of
routine general practice care and several point of care
devices now exist [3]. The CRP assay is used widely in
Nordic countries. In Norway a CRP test is now per-
formed in one out of every 8 consultations and a study
in Sweden in 2002 revealed that a CRP test was carried
out in 41% of all patients consulting a GP with an air-
way infection [4].
A recent systematic review addressing the diagnostic
value of CRP in discriminating between bacterial and
viral infections of the lower respiratory tract [4] called
for further research given the poor methodological qual-
ity of the studies included, and commented that the cur-
rent available evidence was not consistently sufficient in
supporting the use of CRP to guide antibiotic prescrib-
ing in respiratory tract infections.
Of further interest, a subsequent pragmatic trial pub-
lished in the BMJ in 2009 studied general practitioners’
use of C reactive protein testing and training in commu-
nication skills in patients with acute cough. This
demonstrated that both methods resulted in decreased
antibiotic prescribing for lower respiratory tract infec-
tion in primary care. Patient recovery and satisfaction
with care were not compromised and the two
approaches combined resulted in the greatest reduction
in antibiotic prescribing [5]. Other research has sug-
gested that near patient CRP testing in general practice
could lead to a reduction in antibiotic prescribing in
patients with sinusitis [6].
Like most other European countries [7], the majority
of patients in the Republic of Ireland make significant
out of pocket contributions for primary care. In the
Republic of Ireland, free healthcare and medications are
available to patients who qualify under the means-tested
General Medical Scheme (GMS). GMS patients account
for approximately 29% of the population [8] and there-
fore represent the least affluent sector of society. The
remainder, referred to as ‘Private’ patients, whose
income is above a certain level, are required to pay for
all of their own healthcare costs. The necessity for the
majority of the population to pay the out of pocket
costs for GP care in full (typically € 50 per consultation),
adds another significant consumer dimension to the
implementation of CRP testing in Ireland namely the
impact of patient satisfaction and cost on consultations
and outcomes. Therefore, we felt there was a need for a
pilot study in an Irish setting to determine the feasibility
of near patient CRP testing in routine clinical practice
on the treatment of respiratory tract infections. As sug-
gested by Lancaster (2004) [9] and Arain (2010) [10],
specific areas to be reviewed included the integrity of
the study protocol, testing of data collection forma and
acceptability of the intervention.
Method
This was a pilot of 120 patients with a cross-sectional
design. Patients were recruited over a five-month period
from January to May 2011. The first 60 recruited
patients were treated with routine clinical management,
and GP’s had no access to a CRP test. For the subse-
quent 60 patients, access to CRP testing was available.
Each patient completed two initial questions referring to
perceived need for, and expectation of, antibiotic treat-
ment once it was established by the doctor that their
presenting symptoms met inclusion criteria for the
study, prior to examination by the doctor. Patients were
advised to complete the final question in relation to
their level of satisfaction with the consultation on a
Likert scale, when the consultation was complete and
once they had left the consulting room. They were then
asked to leave their completed questionnaire in a sealed
box at the practice reception area. During the same con-
sultation, while the patient was present, the doctor also
completed a similar questionnaire regarding the working
diagnosis and two further questions relating to their
perception of the patient’s expectations in relation to
antibiotic prescription, and their opinion in relation to
clinical indication for antibiotic prescription (after exam-
ination but prior to CRP testing if in that arm of the
study).
At the end of the study period, all three doctors met
in an unstructured format to discuss their reflections on
the study, in particular with reference to perceived
advantages, disadvantages and potential areas for future
use of the CRP test. Identified themes were recorded in
writing by KK,
Setting: The study was carried out in one suburban
general practice in Ireland catering for 6200 patients,
(both GMS and private), by 3 of the 6 general practi-
tioners (Dr’s A, B and C), 2 of whom were employed on
a full time basis and one part- time.
Participants and consent: All adult patients aged 18
years or older with acute cough and/or sore throat with
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cutive sampling method was used by the physicians
involved in the study to select eligible patients in the
course of routine practice. Information posters were
placed in all practice waiting rooms explaining that
patients may be asked to complete a questionnaire and/
or have a blood test if they presented to a physician
w i t hac o u g ha n d / o ras o r et h r o a t .W h e nap a t i e n t
meeting the inclusion criteria presented to one of the
physicians involved (generally apparent once the pre-
senting complaint was elicited by the physician), the
patient was then asked if they would like to take part in
the study. A verbal description of the study was given at
the beginning of each relevant consultation, and the
voluntary nature of participation was emphasized at all
stages. Following full verbal description of the study,
informed consent was obtained verbally from each eligi-
ble patient. For repeat attendances, clinical management
including whether to perform repeat CRP testing, was
entirely at the discretion of the GP involved,
Ethical approval was granted, by the Irish College of
General Practitioners Ethics Committee.
Variables
Primary outcome was antibiotic prescription at the
index consultation.
Secondary outcomes were number of delayed prescrip-
tions issued, re-consultation (referring to both ‘in per-
son’ and telephone consultations) and antibiotic
prescription, both during 28 days of follow-up, and
patient satisfaction. Repeat attendances within 28 days
and antibiotic prescription at re-attendance were
recorded but not included as new patient encounters in
analysis.
Data sources/Measurement: CRP measurements were
performed using the point of care Quik-Read
® CRP kit,
Orion Diagnostica Oy [11]. This device has been vali-
dated in a previous study and has shown good concor-
dance with standard laboratory CRP measurement [12].
There is a general agreement that the normal range of
CRP at all ages is 0-10 mg/l [13]. For the purposes of
our study, a CRP value of less than 20 was considered
indicative of a viral or self-limiting infection. A value of
20-50 was taken to indicate a ‘borderline’ level, (at
which advice would usually be given to observe symp-
toms over 48 hrs with explanation in relation to red flag
symptoms and signs, and the possible issue of a delayed
antibiotic prescription). A level of > 50 was considered
to be indicative of a bacterial infection [14].
Upon completion of the study period, outcome data
was extracted by one of the study coordinators (KK). As
suggested by Lancaster [9] and Arain [10], formal statis-
tical analysis of pilot results was not performed.
Results
Participants
One hundred and twenty participants were recruited in
total, sixty to each arm of the study over a 5-month per-
iod from January to May 2010. All (100%) of patients
recruited in both arms agreed to be involved in the
study. One patient in the ‘CRP arm’ refused a blood test
due to needle phobia; however this patient still agreed
to complete a questionnaire.
Descriptive data
The mean ages of participants were similar in both ‘CRP’
and ‘No CRP’ arms, at 47.6 years (SD 16.3) and 48 years
(SD 17.8) respectively. Forty eight percent of patients in
the ‘No CRP’ group were private, and 52% were GMS
compared to 37% private and 63% GMS in the ‘CRP’
group. In the ‘No CRP’ group, patient questionnaires
were missing for 3 of the 60 participants (5%) and doc-
tor’s questionnaire was missing for 1 participant (1.7%).
In the ‘CRP’ group, patient questionnaires were missing
for 3 of the 60 participants (5%) and there were no miss-
ing doctor’s questionnaires. One patient in the ‘CRP’
group refused the CRP testing due to a needle phobia.
Both groups were broadly similar in terms of working
diagnosis. Thirty-eight patients (63%) in each group
were diagnosed with Upper Respiratory Tract Infections
with 19 (32%) and 16 (27%) diagnosed with Lower
Respiratory tract infections in the ‘No CRP’ and ‘CRP’
groups respectively. (The remainder of patients in each
group, were diagnosed with a respiratory tract infection
whose site was not specified, or had a non- infectious
diagnosis (e.g rhinitis). The consecutive opportunistic
sampling method used meant that participants were not
distributed uniformly between the three physicians
(denoted by letters below) with the breakdown as fol-
lows: Dr A 32% and 22% of participants in the ‘no CRP’
and ‘CRP’ groups respectively, Dr B 38% and 50%
respectively, and Dr C 28% and 43% respectively.
Outcome data
Table 1 outlines the results of the outcomes considered
in this study, comparing the initial ‘no CRP’ arm, where
no CRP assays were performed, and the ‘CRP’ arm
where CRP assays were performed on every patient.
There was a reduction in antibiotic prescribing in the
‘CRP’ arm (45% v 58.3%). A higher proportion of those
w h or e c e i v e da na n t i b i o t i cp r e s c r i p t i o ni nt h e‘CRP’
g r o u pr e c e i v e dad e l a y e da n t ibiotic prescription (37% v
28%). There was also an increase in re-consultation
rates in the ‘CRP’ group with 25% re-presenting with a
similar problem within 1 month, compared to 15% in
the ‘No CRP’ group. Both telephone and in-person con-
sultations were included in the re-consultation figures.
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had a GMS card: 56% in the ‘No CRP’ group versus 78%
in the ‘CRP’ group.
Seventy eight percent (n = 7 out of 9) of those who
re-consulted in the ‘no CRP’ group had received an anti-
biotic prescription in their first consultation, compared
to 57% (n = 8 out of 14) in the ‘CRP’ group.
Of those who re-consulted in the ‘No CRP group’, one
third received an antibiotic prescription, compared to
almost one half of the cohort who re-consulted in the
‘CRP’ group.
Patients’ expectation of receiving an antibiotic pre-
scription was lower in the ‘CRP’ group (36.6% v 48.3%).
There was also a decrease in doctor’s level of uncer-
tainty with regard to antibiotic necessity in the CRP
group with only 1.7% stating they were uncertain as to
whether the patient required an antibiotic after exami-
nation compared to 18.3% of the ‘No CRP’ group.
Doctors’ perception of patient expectation for antibio-
tic prescription differed to patients’ self professed
expectation for antibiotic prescription between the two
groups at 55% v 48.3% in the ‘No CRP’ group and 35%
v 36.6% in the ‘CRP’ group..
Patient satisfaction was similarly high in both groups
with 85% reporting they were ‘Satisfied’ or ‘Very satis-
fied’ with the consultation.
Table 2 outlines the CRP values and antibiotic pre-
scription rates (both immediate and delayed) for patients
in the ‘CRP’ arm of study. The lowest proportion of
patients (8%) had a CRP level > 50 and there was a
100% antibiotic prescription rate in this group, with no
delayed prescriptions. Approximately half of all patients
fell into the ‘borderline’ CRP (20-50) group with an anti-
biotic prescription rate of 56.6%, and just over half of
these (53%) were delayed prescriptions, representing the
highest rate of delayed prescriptions in these 3 sub-
groups. Two fifths of patients had a CRP level of < 20,
with an antibiotic prescribing rate of 20% in this subset.
As mentioned above, one patient refused CRP testing
due to needle phobia.
Table 1 Outcome data
No CRP arm CRP arm
%n % n
Antibiotic prescribed at index consultation 58.3 35 45 27
Immediate antibiotic prescription 71.4 25 63 17
Delayed antibiotic prescriptions 28 10 37 10
Patient’s expectation of antibiotic prescription:
Yes 48.3 29 36.6 22
No 8.3 5 11.7 7
Unsure 40 24 46.7 28
Doctor’s perception of patient’s expectation for antibiotic prescription
Yes 55 33 35 21
No 8.3 5 10 6
Unsure 35 21 55 33
Doctor’s opinion on necessity for antibiotics:
Yes 25 15 18.3 11
No 53.3 32 80 48
Unsure 18.3 11 1.7 1
Re-consult within 28/7 with similar problem 15 9 23 14
% of re-consults who received antibiotic prescription at re-presentation 33.3 3 46.7 7
Patient Satisfaction (Satisfied and Very satisfied) 85 51 85 51
This table depicts the results of the outcomes considered in this study, comparing the initial ‘no CRP’ arm, where no CRP assays were performed, and the ‘CRP’
arm where CRP assays were performed on every patient.
Table 2 ’CRP values and antibiotic prescription in ‘CRP’ arm of study’
CRP Value Immediate Antibiotic prescriptions Delayed antibiotic prescriptions
nn N
< 20 24 (40%) 4 1
20-50 30 (50%) 8 9
> 50 5 (8%) 5 0
This table demonstrates the CRP values and number of immediate and delayed antibiotic prescriptions among patients in the CRP arm of the study. In the table
patients are divided into 3 groups according to CRP level. (Note-1 patient refused a blood test. Percentages are calculated out of 60-the total patient number in
this group.)
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All practitioners agreed that they felt the use of CRP
testing was beneficial and had increased their confidence
to withhold antibiotic prescriptions in certain patients
(for example asthmatics, and patients with cough with
no localizing signs who felt themselves that they should
get an antibiotic prescription). It was highlighted that
performing this test did add cost (to the GP in terms of
test materials used) and time to the consultation. This
time reduced with experience but was estimated at up
to 3 minutes in some consultations. It was postulated
however, that this extra, invested time may have been a
trade-off improving patient education and changing
future behaviour in some cases It was suggested that the
utility of CRP testing may be its role as a rule-in tool in
pivotal patients such as those above, and/or as a bar-
gaining tool in those consultations where there was
some conflict or uncertainty for example where the
patient demanded antibiotics but in whom they were
not felt to be clinically necessary.
Discussion
The protocol and data collection forms worked well and
the intervention of CRP testing appeared acceptable.
Preliminary findings suggest that the use of near-patient
CRP testing may be associated with reduced antibiotic
prescribing for respiratory tract infections, high levels of
patient satisfaction and increased re-consultations.
Implications of pilot
We feel that this pilot study confirms the potential feasi-
bility of a full trial in Irish general practice and reveals
two important lessons. First, it was originally intended
to spend 6 weeks recruiting patients for each study arm,
commencing in January 2010 thus completing data col-
lection at the end of March 2010, however this time
frame was extended as recruitment for the initial arm
proved slower than expected due to an unexpected
reduction in patient attendances in January 2010. This is
in contrast to current (at time of writing) attendances in
the midst of an influenza epidemic, which could poten-
tially be an ideal time to undertake a future study such
as this. Second, the provision of a denominator (i.e doc-
umentation of the total number of eligible patients who
presented during the study period) in a future, more
extensive study would enhance understanding of the
generalisability of study results [15].
Other important learning points, based on analysis of
study results, along with qualitative reflections of practi-
tioners involved were as follows:
Re-consultation rates
We noted an increase in re-consultation rates within
one month of the index consultation in those patients
in the “CRP’ arm. Of note, a higher proportion of
those who re-consulted in the ‘no CRP’ group had
received an antibiotic compared to those who re-con-
sulted in the ‘CRP’ group (78% v 57%). When the base-
line characteristics of both groups are examined, a
larger proportion (63% v 52%)of the ‘CRP’ group had
GMS cards (ie did not pay for consultations), which
m a yh a v eh a da ni n f l u e n c eo n likelihood of re-consul-
tation. A previous large study, looking at the effect of
CRP testing and or communication skills on antibiotic
use in lower respiratory tract infections, found a slight
increase in re-consultation rates using CRP measure-
ment, however this increase was not statistically signif-
icant [5].
Given the small numbers in this study it is difficult to
draw accurate conclusions from the above figures, A
future larger study would need to address the above
trend and seek further definition of the re-consulting
population, including qualitative information on reasons
for re-consultation.
Practice Resources
One factor highlighted in practitioners’ reflections,
which may limit the use of this test in routine practice,
is the financial cost of test materials and reagent, which
many practices could find prohibitive.
Patient satisfaction
We showed that the use of CRP in the management of
respiratory tract infections in our practice did not cause
a reduction in patient satisfaction. We demonstrated a
similarly high level of patient satisfaction in both study
groups and rates of satisfaction were similar in both
GMS and private patients. Only one patient in the study
refused CRP testing and this was due to needle phobia.
Practitioners’ perspectives
In general many of the sentiments expressed by the GP’s
involved in this study echo previously published qualita-
tive research themes in this area [16]
Limitations
Two major limitations in this study are the issues of size
and study duration. This study was conducted in 120
patients in one general practice during only one winter/
spring season. Further studies would need to involve a
larger population over a longer period of time to con-
firm or refute any trends we noted. In a future study
seasonal factors would be taken into account.
Although all study practitioners were in agreement in
terms of criteria for patient eligibility and selection,
future studies may want to refine the consecutive
approach we took to sampling in the course of routine
practice, to reduce any possibility of ‘cherry picking’.
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respiratory tract infections in this study. Much previous
work on the use of CRP levels has been in reference to its
use in lower respiratory tract infections. In addition we did
not document illness duration prior to presentation as a
study outcome. Both of the above factors may have had an
influence on interpretation of CRP values. Previous
research has suggested that raised CRP in viral infections
during the first week can mislead clinicians into prescrib-
ing antibiotics, and have suggested that moderately ele-
vated CRP values in patients with respiratory tract
infection cannot support a diagnosis of bacterial infection
when the illness has lasted less than 7 days [17]. Further
and potentially larger studies may benefit from analyzing
results of upper and lower respiratory tract infections
separately and making note of illness duration.
Conclusions
This pilot study confirms the potential feasibility of a full
trial in Irish general practice. It re-iterates that the use of
near-patient CRP testing may be associated with reduced
antibiotic prescribing for respiratory tract infections and
suggests it may be associated with high levels of patient
satisfaction and increased re-consultations. With the
establishment of the Western Research and Education
Network (WestREN), a new primary care research net-
work in the West of Ireland [18] we now have the poten-
tial to conduct a subsequent larger study through up to
80 general practices covering over 200,000 patients.
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